Psychiatry

In a new study, investigators examine the efficacy and tolerability of antipsychotic medications for patients in remission for psychotic depression.

In a new population-based study, investigators discover sex differences in burdensome interventions and antibiotic therapy for nursing home residents with advanced dementia in Canada.

In an extensive population-based study, investigators link children with IBD with an increased risk of any psychiatric disorder.

The association of depression symptoms with cognition and cortical amyloid measurements could lead to better therapies to prevent Alzheimer disease.

A new study looks at the links between ADHD and bipolar disorder in children and adolescents.

In a new cohort study, investigators examine the link between blood pressure and cognitive decline.

Investigators find that ADHD drug MPH impacts the brain differently depending on age.

In a new multivariable regression study, investigators link depression with a lack of social support and increased IBD activity.

Considerations for improving upon the diagnosis and management of Alzheimer disease.

A clinical breakdown of what constitutes primary, secondary, chronic, and acute forms of insomnia.

How do the states with the longest-running legislation permitting MAID compare?

This week's #DocTalk tweet chat generated discussion on the means by which healthcare professionals can influence mental health policies and understanding.

A 24-week randomized clinical trial found PRT-P led to improvements in social communication skills among children with ASD.

As patients age, they become more susceptible to the cyclical factors that can drive insomnia severity.

Socially active people in the their 50s and 60s have a lower risk of developing dementia, according to a new study.

Days after another couple of mass shooting tragedies, a team of psychiatry thought leaders discuss the public's understanding of mental health care.

New model predicts patients at risk of developing Alzheimer disease up to 2 years in the future.

An overview of exciting, upcoming therapies that may be of interest for the treatment of Alzheimer disease.

Experts discuss the status of clinical trials that explore various monoclonal antibody therapies and BACE inhibitors for the treatment of Alzheimer disease.

A conventional mass-univariate fMRI analysis helps determine patients that exhibit greater pretreatment neural activity.

Sunovion seeking FDA approval for dateline after successful clinical trials treating binge eating disorder.

A cohort study analysis shows clozapine is effective in treating schizophrenia, despite adverse effects.

The rationale for investigating monoclonal antibodies and BACE inhibitors for the treatment of patients with Alzheimer disease.

Drs. Alireza Atri and Ronald C. Petersen remark on the important roles a community neurologist, as well as other members of a patient’s health care team, can play in the management of Alzheimer disease.